BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Majo S, Auguste P. The Yin and Yang of Discoidin Domain Receptors (DDRs): Implications in Tumor Growth and Metastasis Development. Cancers (Basel) 2021;13:1725. [PMID: 33917302 DOI: 10.3390/cancers13071725] [Cited by in Crossref: 1] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Gupta K, Jones JC, Farias VA, Mackeyev Y, Singh PK, Quiñones-Hinojosa A, Krishnan S. Identification of Synergistic Drug Combinations to Target KRAS-Driven Chemoradioresistant Cancers Utilizing Tumoroid Models of Colorectal Adenocarcinoma and Recurrent Glioblastoma. Front Oncol 2022;12:840241. [PMID: 35664781 DOI: 10.3389/fonc.2022.840241] [Reference Citation Analysis]
2 Li X, Chen H, Zhang D. Discoidin domain receptor 1 may be involved in biological barrier homeostasis. J Clin Pharm Ther 2022. [PMID: 35665520 DOI: 10.1111/jcpt.13705] [Reference Citation Analysis]
3 Zhao H, Chen Z, Fang Y, Su M, Xu Y, Wang Z, Gyamfi MA, Zhao J, Zhuo Z. Prediction of Prognosis and Recurrence of Bladder Cancer by ECM-Related Genes. Journal of Immunology Research 2022;2022:1-16. [DOI: 10.1155/2022/1793005] [Reference Citation Analysis]
4 Wu M, Huang Q, Xie Y, Wu X, Ma H, Zhang Y, Xia Y. Improvement of the anticancer efficacy of PD-1/PD-L1 blockade via combination therapy and PD-L1 regulation. J Hematol Oncol 2022;15:24. [PMID: 35279217 DOI: 10.1186/s13045-022-01242-2] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 16.0] [Reference Citation Analysis]
5 Saby C, Maquoi E, Saltel F, Morjani H. Collagen and Discoidin Domain Receptor 1 Partnership: A Multifaceted Role in the Regulation of Breast Carcinoma Cell Phenotype. Front Cell Dev Biol 2021;9:808625. [PMID: 35004699 DOI: 10.3389/fcell.2021.808625] [Reference Citation Analysis]
6 Popova NV, Jücker M. The Functional Role of Extracellular Matrix Proteins in Cancer. Cancers (Basel) 2022;14:238. [PMID: 35008401 DOI: 10.3390/cancers14010238] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 10.0] [Reference Citation Analysis]
7 Piperigkou Z, Karamanos NK. Matrix Effectors and Cancer. Cancers (Basel) 2021;14:200. [PMID: 35008364 DOI: 10.3390/cancers14010200] [Reference Citation Analysis]
8 Chen L, Kong X, Fang Y, Paunikar S, Wang X, Brown JAL, Bourke E, Li X, Wang J. Recent Advances in the Role of Discoidin Domain Receptor Tyrosine Kinase 1 and Discoidin Domain Receptor Tyrosine Kinase 2 in Breast and Ovarian Cancer. Front Cell Dev Biol 2021;9:747314. [PMID: 34805157 DOI: 10.3389/fcell.2021.747314] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
9 Elkamhawy A, Lu Q, Nada H, Woo J, Quan G, Lee K. The Journey of DDR1 and DDR2 Kinase Inhibitors as Rising Stars in the Fight Against Cancer. Int J Mol Sci 2021;22:6535. [PMID: 34207360 DOI: 10.3390/ijms22126535] [Cited by in F6Publishing: 6] [Reference Citation Analysis]